• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2018 至 2020 年糖尿病设备不良事件数据。

Adverse Event Data for Years 2018 to 2020 for Diabetes Devices.

机构信息

Krouwer Consulting, Sherborn, MA, USA.

出版信息

J Diabetes Sci Technol. 2022 Sep;16(5):1299-1302. doi: 10.1177/19322968211011688. Epub 2021 May 8.

DOI:10.1177/19322968211011688
PMID:33969718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9445356/
Abstract

Unlike performance evaluations, which are often conducted under ideal conditions, adverse events occur during actual device use for people with diabetes. This report summarizes the number of adverse events for the years 2018 to 2020 for the 3 diabetes devices: blood glucose meters (BG), continuous glucose monitors (CGM), and insulin pumps. A text example of a CGM injury is provided. Possible reasons are suggested for trends. Whereas the rate per test result (events/usage) is exceedingly small, the rate per patient (events/people with diabetes that use insulin) is of concern. Hence, it is important to determine event causes and provide corrective actions. The first step is to put in place routine analysis of adverse event data for diabetes devices.

摘要

与通常在理想条件下进行的绩效评估不同,在糖尿病患者实际使用设备时会发生不良事件。本报告总结了 2018 年至 2020 年 3 种糖尿病设备(血糖仪 (BG)、连续血糖监测仪 (CGM) 和胰岛素泵)的不良事件数量。提供了 CGM 损伤的文本示例。针对趋势提出了可能的原因。虽然每次测试结果(事件/使用)的发生率极低,但每例患者(使用胰岛素的糖尿病患者)的发生率令人担忧。因此,确定事件原因并采取纠正措施非常重要。第一步是对糖尿病设备的不良事件数据进行常规分析。

相似文献

1
Adverse Event Data for Years 2018 to 2020 for Diabetes Devices.2018 至 2020 年糖尿病设备不良事件数据。
J Diabetes Sci Technol. 2022 Sep;16(5):1299-1302. doi: 10.1177/19322968211011688. Epub 2021 May 8.
2
An Analysis of 2019 FDA Adverse Events for Two Insulin Pumps and Two Continuous Glucose Monitors.2019 年两种胰岛素泵和两种连续血糖监测仪的 FDA 不良事件分析。
J Diabetes Sci Technol. 2022 Jan;16(1):228-232. doi: 10.1177/1932296820951872. Epub 2020 Sep 3.
3
Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.1 型糖尿病患者的连续血糖监测和连续皮下胰岛素输注装置的皮肤反应。
J Diabetes Sci Technol. 2021 Jul;15(4):786-791. doi: 10.1177/1932296820918894. Epub 2020 May 9.
4
Exercise habits and glucose management among older adults with type 1 diabetes using insulin pumps.使用胰岛素泵的老年1型糖尿病患者的运动习惯与血糖管理
Acta Diabetol. 2022 Jun;59(6):865-868. doi: 10.1007/s00592-022-01858-3. Epub 2022 Mar 1.
5
A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes.一名1型糖尿病儿童胰岛素泵使用部位出现的一种新描述的皮肤反应。
Pediatr Dermatol. 2021 Jan;38(1):239-241. doi: 10.1111/pde.14438. Epub 2020 Nov 10.
6
Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017.1995 年至 2017 年期间,1 型糖尿病患儿、青少年和成人中胰岛素泵治疗和血糖监测的时间趋势和当代应用。
Diabetes Care. 2019 Nov;42(11):2050-2056. doi: 10.2337/dc19-0345. Epub 2019 Sep 5.
7
The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.持续皮下胰岛素泵联合持续血糖监测在门诊1型糖尿病青少年患者中的有效性:一项系统评价。
JBI Libr Syst Rev. 2012;10(42 Suppl):1-10. doi: 10.11124/jbisrir-2012-170.
8
First Randomized Controlled Trial of Hybrid Closed Loop Versus Multiple Daily Injections or Insulin Pump Using Self-Monitoring of Blood Glucose in Free-Living Adults with Type 1 Diabetes Undertaking Exercise.第一项针对1型糖尿病成年患者在自由生活状态下进行运动时,比较混合闭环系统与多次皮下注射或胰岛素泵并采用自我血糖监测的随机对照试验。
J Diabetes Sci Technol. 2021 Nov;15(6):1399-1401. doi: 10.1177/19322968211035110. Epub 2021 Jul 27.
9
Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.在接受持续皮下胰岛素输注或强化每日多次注射治疗的1型糖尿病儿童中长时间使用持续葡萄糖监测仪。
Pediatr Diabetes. 2009 Apr;10(2):91-6. doi: 10.1111/j.1399-5448.2008.00476.x. Epub 2008 Oct 20.
10
Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.小剂量胰高血糖素治疗 1 型糖尿病成人非重度低血糖的疗效和安全性。
J Clin Endocrinol Metab. 2017 Aug 1;102(8):2994-3001. doi: 10.1210/jc.2017-00591.

引用本文的文献

1
Performance of a Continuous Subcutaneous Insulin Infusion (CSII) Pump With Acoustic Volume and Flow Sensing in Simulated High-Consequence Situations.在模拟高风险情况下,采用声学体积和流量传感的持续皮下胰岛素输注(CSII)泵的性能。
IEEE Open J Eng Med Biol. 2024 Jun 4;5:593-599. doi: 10.1109/OJEMB.2024.3408092. eCollection 2024.
2
Severe Insulin Pump-Related Adverse Events: Potential Root Causes and Impact of the COVID-19 Pandemic.严重的胰岛素泵相关不良事件:潜在根本原因及新冠疫情的影响
J Diabetes Sci Technol. 2024 May 28:19322968241254521. doi: 10.1177/19322968241254521.
3
Insulin Pump-Associated Adverse Events in a Brazilian Reference Center for the Treatment of Diabetes Mellitus: Proposal for a Taxonomy of Device Failures in Adults, Adolescents, and Children.巴西糖尿病治疗参考中心胰岛素泵相关不良事件:成人、青少年和儿童设备故障分类法建议
J Diabetes Sci Technol. 2024 Jan;18(1):74-81. doi: 10.1177/19322968221106196. Epub 2022 Jun 30.
4
Analysis of "Multicenter Evaluation Study Comparing a New Factory-Calibrated Real-Time Continuous Glucose Monitoring System to Existing Flash Glucose Monitoring System".《多中心评价研究:比较新型工厂校准实时连续血糖监测系统与现有瞬态血糖监测系统》分析。
J Diabetes Sci Technol. 2023 Jan;17(1):214-216. doi: 10.1177/19322968211046026. Epub 2021 Oct 15.

本文引用的文献

1
More Focus is Needed to Reduce Adverse Events for Diabetes Devices.需要更多关注以减少糖尿病设备的不良事件。
J Diabetes Sci Technol. 2022 Mar;16(2):498-499. doi: 10.1177/1932296820951625. Epub 2020 Sep 8.
2
An Analysis of 2019 FDA Adverse Events for Two Insulin Pumps and Two Continuous Glucose Monitors.2019 年两种胰岛素泵和两种连续血糖监测仪的 FDA 不良事件分析。
J Diabetes Sci Technol. 2022 Jan;16(1):228-232. doi: 10.1177/1932296820951872. Epub 2020 Sep 3.
3
Insulin Access and Affordability Working Group: Conclusions and Recommendations.胰岛素可及性与可负担性工作组:结论与建议
Diabetes Care. 2018 Jun;41(6):1299-1311. doi: 10.2337/dci18-0019. Epub 2018 May 8.
4
What Can We Learn From Point-of-Care Blood Glucose Values Deleted and Repeated by Nurses?我们能从护士删除并重新记录的即时血糖值中学到什么?
J Diabetes Sci Technol. 2018 Sep;12(5):985-991. doi: 10.1177/1932296818763891. Epub 2018 Mar 24.
5
Improving the clinical value and utility of CGM systems: issues and recommendations : A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.提高 CGMS 系统的临床价值和实用性:问题与建议——欧洲糖尿病研究协会与美国糖尿病协会糖尿病技术工作组联合声明
Diabetologia. 2017 Dec;60(12):2319-2328. doi: 10.1007/s00125-017-4463-4. Epub 2017 Oct 25.
6
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.胰岛素泵的风险与益处:对泵安全标准、不良事件报告和研究需求的临床评估:欧洲糖尿病研究协会和美国糖尿病协会糖尿病技术工作组的联合声明。
Diabetes Care. 2015 Apr;38(4):716-22. doi: 10.2337/dc15-0168.